Litcius/Paper detail

Atezolizumab and blockade of LncRNA PVT1 attenuate cisplatin resistant ovarian cancer cells progression synergistically via JAK2/STAT3/PD-L1 pathway

Ying Chen, Fangxuan Li, Dan Li, Wenxin Liu, Lei Zhang

2021Clinical Immunology45 citationsDOI

Topics & Concepts

PVT1Cancer researchCisplatinOvarian cancerGene knockdownPD-L1ApoptosisImmune checkpointSTAT3ChemistryCancerBiologyMedicineImmunotherapyLong non-coding RNAInternal medicineChemotherapyDownregulation and upregulationBiochemistryGeneCancer-related molecular mechanisms researchFerroptosis and cancer prognosisKruppel-like factors research
Atezolizumab and blockade of LncRNA PVT1 attenuate cisplatin resistant ovarian cancer cells progression synergistically via JAK2/STAT3/PD-L1 pathway | Litcius